4
Changes in Ownership
Zentalis Pharmaceuticals, Inc. Filed Acc 0001628280-26-064317
Chief Medical Officer acquired 9,727 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Bruns Ingmar · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-09-30 | Grant or award : show line 1 in the form | +9,727 | $2.18 | $21,205 | 43,059 | D |
Loading xslF345X06/wk-form4_1790889591.xml…